Trial Profile
EFFECTIVENESS OF THE LEVOSIMENDAN IN THE THERAPY OF DIASTOLIC DYSFUNCTION OF CARDIAC SURGERY.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 May 2011
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Diastolic heart failure
- Focus Therapeutic Use
- 17 May 2011 New trial record